Morgan Stanley Maintains Equal-Weight on BJ’s Wholesale Club, Raises Price Target to $77
Morgan Stanley analyst Simeon Gutman maintains BJ's Wholesale Club (NYSE:BJ) with a Equal-Weight and raises the price target from $76 to $77.
Morgan Stanley Maintains Equal-Weight on Asana, Raises Price Target to $22
Morgan Stanley analyst Josh Baer maintains Asana (NYSE:ASAN) with a Equal-Weight and raises the price target from $19 to $22.
Credit Suisse Reiterates Outperform on Galecto, Maintains $6 Price Target
Credit Suisse analyst Tiago Fauth reiterates Galecto (NASDAQ:GLTO) with a Outperform and maintains $6 price target.
Credit Suisse Maintains Outperform on Ulta Beauty, Raises Price Target to $580
Credit Suisse analyst Michael Binetti maintains Ulta Beauty (NASDAQ:ULTA) with a Outperform and raises the price target from $535 to $580.
Credit Suisse Maintains Outperform on Olema Pharmaceuticals, Lowers Price Target to $11
Credit Suisse analyst Richard Law maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and lowers the price target from $12 to $11.
JP Morgan Maintains Overweight on Pliant Therapeutics, Lowers Price Target to $47
JP Morgan analyst Eric Joseph maintains Pliant Therapeutics (NASDAQ:PLRX) with a Overweight and lowers the price target from $51 to $47.
JP Morgan Maintains Neutral on FirstEnergy, Lowers Price Target to $41
JP Morgan analyst Jeremy Tonet maintains FirstEnergy (NYSE:FE) with a Neutral and lowers the price target from $43 to $41.
JP Morgan Maintains Overweight on American Electric Power, Lowers Price Target to $102
JP Morgan analyst Jeremy Tonet maintains American Electric Power (NASDAQ:AEP) with a Overweight and lowers the price target from $105 to $102.
JP Morgan Maintains Overweight on Oracle, Raises Price Target to $93
JP Morgan analyst Mark Murphy maintains Oracle (NYSE:ORCL) with a Overweight and raises the price target from $87 to $93.
Janney Montgomery Scott Initiates Coverage On Farmers National Banc with Neutral Rating, Announces Price Target of $14
Janney Montgomery Scott analyst Daniel Cardenas initiates coverage on Farmers National Banc (NASDAQ:FMNB) with a Neutral rating and announces Price Target of $14.